A mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial

被引:217
|
作者
Heijnen, Esther M. E. W.
Eijkemans, Marinus J. C.
De Klerk, Cora
Polinder, Suzanne
Beckers, Nicole G. M.
Klinkert, Ellen R.
Broekmans, Frank J.
Passchier, Jan
Macklon, Nick S.
Fauser, Bart C. J. M.
机构
[1] Univ Med Ctr, Dept Reprod Med & Gynaecol, NL-3584 CX Utrecht, Netherlands
[2] Erasmus MC, Dept Med Psychol & Psychotherapy, Rotterdam, Netherlands
[3] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands
[4] Erasmus MC, Div Reprod Med, Rotterdam, Netherlands
来源
LANCET | 2007年 / 369卷 / 9563期
关键词
D O I
10.1016/S0140-6736(07)60360-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Mild in-vitro fertilisation (IVF) treatment might lessen both patients' discomfort and multiple births, with their associated risks. We aimed to test the hypothesis that mild IVF treatment can achieve the same chance of a pregnancy resulting in term livebirth within 1 year compared with standard treatment, and can also reduce patients' discomfort, multiple pregnancies, and costs. Methods We did a randomised, non-inferiority effectiveness trial. 404 patients were randomly assigned to undergo either mild treatment (mild ovarian stimulation with gonadotropin-releasing hormone [GnRH] antagonist cotreatment combined with single embryo transfer) or a standard treatment (stimulation with a GnRH agonist long-protocol and transfer of two embryos). Primary endpoints were proportion of cumulative pregnancies leading to term livebirth within 1 year after randomisation (with a non-inferiority threshold of -12.5%), total costs per couple up to 6 weeks after expected date of delivery, and overall discomfort for patients. Analysis was by intention to treat. This trial is registered as an International Standard Randomised Clinical Trial, number ISRCTN35766970. Findings The proportions of cumulative pregnancies that resulted in term livebirth after 1 year were 43.4% with mild treatment and 44.7% with standard treatment (absolute number of patients=86 for both groups). The lower limit of the one-sided 95% CI was -9.8%. The proportion of couples with multiple pregnancy outcomes was 0.5% with mild IVF treatment versus 13.1% (p<0.0001) with standard treatment, and mean total costs were E8333 and E10745, respectively (difference E2412, 95% CI 703-4131). There were no significant differences between the groups in the anxiety depression, physical discomfort, or sleep quality of the mother. Interpretation Over 1 year of treatment, cumulative rates of term livebirths and patients' discomfort are much the same for mild ovarian stimulation with single embryos transferred and for standard stimulation with two embryos transferred. However, a mild IVF treatment protocol can substantially reduce multiple pregnancy rates and overall costs.
引用
收藏
页码:743 / 749
页数:7
相关论文
共 50 条
  • [31] Chapter 6 Non-inferiority Trial
    Peter Pang
    [J]. 实用休克杂志(中英文), 2019, 3 (04) : 254 - 256
  • [32] Conventional in-vitro fertilisation versus intracytoplasmic sperm injection for the treatment of non-male-factor infertility: a randomised controlled trial
    Bhattacharya, S
    Hamilton, MPR
    Shaaban, M
    Khalaf, Y
    Seddler, M
    Ghobara, T
    Braude, P
    Kennedy, R
    Rutherford, A
    Hartshorne, G
    Templeton, A
    [J]. LANCET, 2001, 357 (9274): : 2075 - 2079
  • [33] Factors affecting the uptake of screening: A randomised controlled non-inferiority trial comparing a genotypic and a phenotypic strategy for screening for haemochromatosis
    Patch, C
    Roderick, P
    Rosenberg, W
    [J]. JOURNAL OF HEPATOLOGY, 2005, 43 (01) : 149 - 155
  • [34] Restrictive transfusion strategy for critically injured patients (RESTRIC) trial: a study protocol for a cluster-randomised, crossover non-inferiority trial
    Hayakawa, Mineji
    Tagami, Takashi
    IIjima, Hiroaki
    Kudo, Daisuke
    Sekine, Kazuhiko
    Ogura, Takayuki
    Yumoto, Tetsuya
    Kondo, Yutaka
    Endo, Akira
    Ito, Kaori
    Matsumura, Yosuke
    Kushimoto, Shigeki
    [J]. BMJ OPEN, 2020, 10 (09):
  • [35] Hysteroscopy in recurrent in-vitro fertilisation failure (TROPHY): a multicentre, randomised controlled trial
    El-Toukhy, Tarek
    Campo, Rudi
    Khalaf, Yacoub
    Tabanelli, Carla
    Gianaroli, Luca
    Gordts, Sylvie S.
    Gordts, Stephan
    Mestdagh, Greet
    Mardesic, Tonko
    Voboril, Jan
    Marchino, Gian L.
    Benedetto, Chiara
    Al-Shawaf, Talha
    Sabatini, Luca
    Seed, Paul T.
    Gergolet, Marco
    Grimbizis, Grigoris
    Harb, Hoda
    Coomarasamy, Arri
    [J]. LANCET, 2016, 387 (10038): : 2614 - 2621
  • [36] A mild ovarian stimulation strategy in women with poor ovarian reserve undergoing IVF: a multicenter randomized non-inferiority trial
    Youssef, M. A.
    van Wely, M.
    Al-Inany, H.
    Madani, T.
    Jahangiri, N.
    Khodabakhshi, S.
    Alhalabi, M.
    Akhondi, M.
    Ansaripour, S.
    Tokhmechy, R.
    Zarandi, L.
    Rizk, A.
    El-Mohamedy, M.
    Shaeer, E.
    Khattab, M.
    Mochtar, M. H.
    van der Veen, F.
    [J]. HUMAN REPRODUCTION, 2017, 32 (01) : 112 - 118
  • [37] Telephone administered cognitive behaviour therapy for treatment of obsessive compulsive disorder: randomised controlled non-inferiority trial
    Lovell, Karina
    Cox, Debbie
    Haddock, Gillian
    Jones, Christopher
    Raines, David
    Garvey, Rachel
    Roberts, Clrris
    Hadley, Sarah
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2006, 333 (7574): : 883 - 886
  • [38] Home treatment of COPD exacerbation selected by DECAF score: a non-inferiority, randomised controlled trial and economic evaluation
    Echevarria, Carlos
    Gray, Joanne
    Hartley, Tom
    Steer, John
    Miller, Jonathan
    Simpson, A. John
    Gibson, G. John
    Bourke, Stephen C.
    [J]. THORAX, 2018, 73 (08) : 713 - 722
  • [39] Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial
    Maertens, Johan A.
    Rahav, Galia
    Lee, Dong-Gun
    Ponce-de-Leon, Alfredo
    Ramirez Sanchez, Isabel Cristina
    Klimko, Nikolay
    Sonet, Anne
    Haider, Shariq
    Diego Velez, Juan
    Raad, Issam
    Koh, Liang-Piu
    Karthaus, Meinolf
    Zhou, Jianying
    Ben-Ami, Ronen
    Motyl, Mary R.
    Han, Seongah
    Grandhi, Anjana
    Waskin, Hetty
    [J]. LANCET, 2021, 397 (10273): : 499 - 509
  • [40] Randomised clinical non-inferiority trial comparing two formulations of desoxycortone pivalate for the treatment of canine primary hypoadrenocorticism
    Farr, Hayley
    Mason, Beasley L.
    Longhofer, Susan L.
    [J]. VETERINARY RECORD, 2020, 187 (02)